This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • Cancer-Associated Thrombosis
  • /
  • NCCN Guidelines Insights: Cancer-Associated Venous...
Guideline

NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018

Read time: 1 mins
Last updated:1st Nov 2018
Status: Live
NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018


Venous thromboembolism (VTE) is common in patients with cancer and increases morbidity and mortality. VTE prevention and treatment are more complex in patients with cancer. The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease outline strategies for treatment and prevention of VTE in adult patients diagnosed with cancer or in whom cancer is clinically suspected. These NCCN Guidelines Insights explain recent changes in anticoagulants recommended for the treatment of cancer-associated VTE.

Read full guidelines